- Home
- IROQ vs ATRA Comparison
IROQ vs ATRA Comparison
Compare IROQ & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IROQ
- ATRA
- Stock Information
- Founded
- IROQ 1883
- ATRA 2012
- Country
- IROQ United States
- ATRA United States
- Employees
- IROQ N/A
- ATRA N/A
- Industry
- IROQ Savings Institutions
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IROQ Finance
- ATRA Health Care
- Exchange
- IROQ Nasdaq
- ATRA Nasdaq
- Market Cap
- IROQ 79.4M
- ATRA 67.9M
- IPO Year
- IROQ 2011
- ATRA 2014
- Fundamental
- Price
- IROQ $25.15
- ATRA $12.34
- Analyst Decision
- IROQ
- ATRA Strong Buy
- Analyst Count
- IROQ 0
- ATRA 3
- Target Price
- IROQ N/A
- ATRA $21.00
- AVG Volume (30 Days)
- IROQ 964.0
- ATRA 50.8K
- Earning Date
- IROQ 09-02-2025
- ATRA 08-11-2025
- Dividend Yield
- IROQ 1.59%
- ATRA N/A
- EPS Growth
- IROQ 69.23
- ATRA N/A
- EPS
- IROQ 1.05
- ATRA 0.56
- Revenue
- IROQ $25,099,000.00
- ATRA $188,667,000.00
- Revenue This Year
- IROQ N/A
- ATRA N/A
- Revenue Next Year
- IROQ N/A
- ATRA N/A
- P/E Ratio
- IROQ $24.02
- ATRA $21.91
- Revenue Growth
- IROQ 12.02
- ATRA 202.41
- 52 Week Low
- IROQ $17.42
- ATRA $5.01
- 52 Week High
- IROQ $25.76
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- IROQ 62.40
- ATRA 60.31
- Support Level
- IROQ $24.90
- ATRA $11.20
- Resistance Level
- IROQ $25.29
- ATRA $12.09
- Average True Range (ATR)
- IROQ 0.06
- ATRA 0.94
- MACD
- IROQ 0.01
- ATRA -0.04
- Stochastic Oscillator
- IROQ 62.22
- ATRA 92.66
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).